Arbutus Biopharma Corp Annual Return On Assets in % from 2014 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Arbutus Biopharma Corp quarterly/annual Return On Assets history and growth rate from 2014 to 2023.
  • Arbutus Biopharma Corp Return On Assets for the quarter ending June 30, 2024 was -50.3 %, a 32.2% decline year-over-year.
  • Arbutus Biopharma Corp annual Return On Assets for 2023 was -43.4 %, a 33.1% decline from 2022.
  • Arbutus Biopharma Corp annual Return On Assets for 2022 was -32.6 %, a 30.3% increase from 2021.
  • Arbutus Biopharma Corp annual Return On Assets for 2021 was -46.8 %, a 14% increase from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -43.4 -10.8 -33.1% Jan 1, 2023 Dec 31, 2023
2022 -32.6 +14.2 +30.3% Jan 1, 2022 Dec 31, 2022
2021 -46.8 +7.63 +14% Jan 1, 2021 Dec 31, 2021
2020 -54.4 +44 +44.7% Jan 1, 2020 Dec 31, 2020
2019 -98.5 -76.1 -340% Jan 1, 2019 Dec 31, 2019
2018 -22.4 +11.4 +33.7% Jan 1, 2018 Dec 31, 2018
2017 -33.8 +42.1 +55.5% Jan 1, 2017 Dec 31, 2017
2016 -75.9 -67.5 -806% Jan 1, 2016 Dec 31, 2016
2015 -8.37 +21.9 +72.3% Jan 1, 2015 Dec 31, 2015
2014 -30.2 Jan 1, 2014 Dec 31, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.